Assessing biosimilars in practice: considerations for the hospital pharmacist to evaluate

被引：0
|
作者：
Tredree, Roger
机构：
来源：
EJHP PRACTICE | 2009年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：28 / 30
页数：3
相关论文
共 50 条
  • [41] Biosimilars: Implications for Clinical Practice
    Rifkin, Robert M.
    Peck, Susan R.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (09) : 24S - +
  • [42] Assessing Development Needs for Biobetters and Biosimilars
    Satterwhite, Christina
    BIOPHARM INTERNATIONAL, 2013, 26 (02) : 28 - +
  • [43] Analytical strategies for assessing comparability of biosimilars
    Falconer, Robert J.
    Jackson-Matthews, Dianne
    Mahler, Stephen M.
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2011, 86 (07) : 915 - 922
  • [44] PRIMARY CONSIDERATIONS FOR SURGICAL PHARMACIST
    MILLER, RY
    JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1975, NS15 (05): : 251 - 253
  • [45] Assessing the bioequivalence of biosimilars The Retacrit® case
    Schellekens, H.
    DRUG DISCOVERY TODAY, 2009, 14 (9-10) : 495 - 499
  • [46] Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study
    Durand, Amaury
    Gillibert, Andre
    Membre, Sophie
    Mondet, Lisa
    Lenglet, Aurelie
    Mary, Aurelien
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] Statistical methods for assessing interchangeability of biosimilars
    Chow, Shein-Chung
    Yang, Lan-Yan
    Starr, Aijing
    Chiu, Shih-Ting
    STATISTICS IN MEDICINE, 2013, 32 (03) : 442 - 448
  • [48] Enabling Expanded Scope in Hospital Practice: Implementation of a Pharmacist Modification Orders Protocol
    Carlin, S.
    Wynne, C.
    Tonkin, M.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2018, 71 (01): : 85 - 85
  • [49] The role of hospital pharmacist
    中国医院药学杂志, 2009, 29 (18) : 1602 - 1603
  • [50] The pharmacist, the network and the hospital
    Solignac, M
    PRESSE MEDICALE, 1999, 28 (06): : 319 - 319
12345